UCB and Biogen (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, or DZP, a novel Fc-free anti-CD40L drug candidate, demonstrating significant ...
(RTTNews) - UCB and Biogen Inc. (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, a Fc-free anti-CD40L drug candidate, showing significant clinical ...
Screenshot of the Go Study Now ad-free study app showing quiz and progress features. Go Study Now founder, Tariq Rufino, aims to make learning free and ad-free for South Africa’s youth. Go Study Now ...
Three days of electric Pokémon. October is a busy month for Pokémon Go fans. Already, the Daily PokeCoin Bounty Part 2 ticket has kicked off, while a Mega Mawile Raid Day and Magnetic Study event are ...
UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...
Diwas Budhathoki, the dedicated Pokemon aficionado, is your guide into the Pokemon franchise. His eSports writing journey began years ago, and he's been sharing his passion through GameRant since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results